The aim of this study was to make a comparison between the results obtained by cytologies and by the detection and genotyping of human papillomavirus (HPV) DNA in the screening of cervical cancer. In this study, there were 994 samples used from human females. These were obtained from liquid-based preparations. The samples were analyzed by cytological technique and by the detection of HPV DNA using the PapilloCheck® Test. The HPV was detected in 28% of the samples. Most of the cytology lesions appeared in HPV positive samples and, within these, the most serious injuries occurred mostly in samples with multiple HPV infections. The results indicate that, in general, there is a correlation between the detection of HPV DNA and cytology. However, there were some cases that emphasize the limitations of both diagnosis methods (27% cases with viral HPV DNA positive and normal cytologies and about 2% of cytological lesions detected in samples HPV negatives). It is possible to conclude that none of the two techniques is enough by itself and should be applied together in order to increase the accuracy of cervical cancer screening.
1. S. Shukla 2009 Infection of human papillomaviruses in cancers of different human organ sites Indian J Med Res 1303 222 233.
2. J.T.T. Nakagawal 2010 Vírus HPV e câncer de colo de útero Rev Bras Enferm 63 2 307 311.
3. J. Su 2010 Immunotherapy for cervical cancer: research status and clinical potential Biodrugs 24 2 109 129.
4. S. Leon 2011 Distribution patterns of infection with multiple types of human papillomaviruses and their association with risk factors Publ Libr Sci — PloS ONE. 6 2 1 7.
5. Ventura MT et al. (2008): Vacinação contra infeções por Vírus do Papiloma Humano (HPV). Direcção-Geral da Saúde.
6. L. Bruni 2010 Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings J Infect Dis 202 12 1789 1799.
7. A. Pista 2011 Prevalence of human papillomavirus infection in women in Portugal — the CLEOPATRE Portugal study Int J Gynecol Cancer 21 6 1150 1158.
8. B.S. Apgar 2003 The 2001 Bethesda System Terminology Am Fam Phys 68 10 1993 1998.
9. Z. Guglielmo A. Rodriguez 2010 Métodos utilizados en la identificacióndelvirus de papiloma humano An del Sist Sanit Navar 33 1 71 77.
10. M.P. Cañadas 2006 Evaluación de las técnicas de deteccióndel VPH en los programas de cribado para cáncer de cuellzo uterino Salud Públ Méx 48 5 373 378.
11. S. Tsiodras 2010 Hybrid capture vs. PCR screening of cervical human papilloma virus infections. Cytological and histological associations in 1270 women Biomed Cent Cancer 10 53 1 8.
12. V. Dalsteina 2009 Analytical evaluation of the PapilloCheck test, a new commercial DNA chip for detection and genotyping of human papillomavirus J Virol Method 156 77 83.
13. Pacheco A et al. (2011): Consenso sobre infecção HPV e lesões intraepiteliais do colo, vagina e vulva. Sociedade Portuguesa de Ginecologia; Secção Portuguesa de Colposcopia e Patologia Cervico-Vulvovaginal.
14. M. Poljak B.J. Kocjan 2010 Commercially available assays for multiplex detection of alpha human papillomaviruses Expert Rev Anti-Infect Ther 8 10 1139 1162.
15. P.J.F. Snijders 2010 Methods for HPV detection in exfoliated cell and tissue specimens Acta Pathol Microbiol Immunol Scand 118 6–7 520 528.
16. J. Cuzick 1999 HPV testing in primary screening of older women Br J Cancer 81 3 554 558.
17. A.T. Hesselink 2010 Comparison of the clinical performance of PapilloCheck human papillomavirus detection with that of the GP5+/6+-PCR enzyme immunoassay in populationbased cervical screening J Clin Microbiol 483 797 801.
18. Greiner Bio-One GmbH (2009): PapilloCheck® Manual. Germany.
19. Decreto LeiN° 190 — 17 de Agosto de 2001. Diário da República n° 129/2001-I Série-B. Ministério da Saúde, Lisboa.
20. Hologic, Inc. 2000 The Thin-Prep Pap Test Hologic, Inc New York, USA.
21. Greiner Bio-One GmbH (2009): PapilloCheck® DNA Extraction kit — Instructions for Use, Germany.
22. Rosenblatt C (2011): HPV (Papilomavírus humano). Brasil: hpvinfo http://www.hpvinfo.com.br/hpv-livro.htm.
23. S. Sanjose 2007 Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis Lancet Infect Dis 7 453 459.
24. N. Muñoz 2003 Epidemiologic classification of human papillomavirus types associated with cervical cancer N Engl J Med 3486 518 527.
25. G.M. Clliford IARC HPV Prevalence Surveys Study Group 2005 Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis Lancet 366 991 998.
26. R.J. Nobre 2010 Characterization of common and rare human papillomaviruses in Portuguese women by the polymerase chain reaction, restriction fragment length polymorphism and sequencing J Med Virol 826 1024 1032.
27. E. Murta 2000 Incidence of Gardnerella vaginalis, Candida sp. and human papilloma virus in cytological smears São Paulo Med J 118 4 105 108.
28. E. Samoff 2005 Association of Chlamydia trachomatis with persistence of high-risk types of human papillomavirus in a cohort of female adolescents Am J Epidemiol 16279 668 675.
29. C.Y. Lee W. Ng 2007 A follow-up study of atypical squamous cells in gynecologic cytology using conventional papanicolaou smears and liquid-based preparations Am J Clin Pathol 127 548 555.
30. A. Nascimento E.S. Cibas 2007 The ASC/SIL ratio for cytopathologists as a quality control measure Am J Clin Pathol 128 653 656.
31. Gouveia S (2009): Detecção de DNA de HPV oncogénico por captura híbrida em citologias normais. Dissertation, Universidade de Aveiro.
32. H. Trottier 2006 Human papillomavirus infections with multiple types and risk of cervical neoplasia Cancer Epidemiol Biomark Prev 15 7 1274 1280.
33. Pereira AST (2010): Genotipagem do vírus do Papiloma Humano em citologia cérvico-vaginal. Dissertation, Universidade de Aveiro.
34. A. Pista 2011 Single and multiple human papillomavirus infections in cervical abnormalities in Portuguese women Clin Microbiol Infect 17 941 946.
35. Cavaco A et al. (2010): Vacinas contra o HPV — Reunião de Consenso Nacional. Sociedade Portuguesa de Ginecologia, 1–27.